Bionova Lt - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 208,566 | 333,019 | 359,273 | 478,518 | 876,895 | 625,270 | 606,944 | 647,621 |
| Profit before tax | - | - | 135,839 | 193,352 | 457,724 | 169,080 | 126,197 | 80,736 |
| Net profit | 1,881 | 61,952 | 115,340 | 163,789 | 388,823 | 143,522 | 107,054 | 67,840 |
| Equity | 114,349 | 176,311 | 232,827 | 320,297 | 590,812 | 371,315 | 368,100 | 381,504 |
| Liabilities | 18,625 | 36,925 | 98,779 | 26,547 | 32,024 | 47,838 | 27,188 | 54,606 |
| Non-current assets | 32,383 | 31,921 | 25,274 | 24,623 | 59,046 | 46,141 | 70,949 | 109,748 |
| Current assets | 99,607 | 179,968 | 305,059 | 321,462 | 562,706 | 374,091 | 353,651 | 374,282 |
| Total assets | 131,990 | 211,889 | 330,333 | 346,085 | 621,752 | 420,232 | 424,600 | 484,030 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 234,625 | 117,675 | 75,198 |
| Social insurance contributions | - | - | - | - | - | 30,204 | 27,213 | 34,379 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -5.0% | +59.7% | +7.9% | +33.2% | +83.3% | -28.7% | -2.9% | +6.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 1.4% | 29.2% | 34.9% | 47.3% | 62.5% | 34.2% | 25.2% | 14.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 1.6% | 35.1% | 49.5% | 51.1% | 65.8% | 38.7% | 29.1% | 17.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.9% | 18.6% | 32.1% | 34.2% | 44.3% | 23.0% | 17.6% | 10.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | 37.8% | 40.4% | 52.2% | 27.0% | 20.8% | 12.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.2 | 0.2 | 0.4 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 38,504 | 51,899 | 97,983 | 100,741 | 169,721 | 127,173 | 108,707 | 86,349 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Bionova Lt - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-07-19 | 2026-07-20 | 3623.40 |
| 2026-07-16 | 2026-07-17 | 3623.40 |
| 2023-03-16 | 2023-03-19 | 2.60 |
| 2023-02-17 | 2023-03-02 | 2.60 |
| 2023-02-06 | 2023-02-06 | 2.60 |
| 2023-01-23 | 2023-02-03 | 2.60 |
| 2022-11-17 | 2022-11-18 | 2170.00 |
Bionova Lt - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Bionova Lt, UAB (code 302290758) is a Private Limited Liability Company operating in materials recovery. In 2025, the company generated EUR 647.6K in revenue, up 6.7% year on year, and recorded net profit of EUR 67.8K, with a profit margin of 10.5%. Over the last three years, revenue moved from EUR 625.3K in 2023 to EUR 606.9K in 2024 and then recovered in 2025, while net profit declined from EUR 143.5K to EUR 107.1K and then to EUR 67.8K. The 2025 balance sheet shows total assets of EUR 484.0K, equity of EUR 381.5K and liabilities of EUR 54.6K, indicating a strong equity position and low leverage. Key ratios for 2025 include ROE of 17.8%, ROA of 14.0%, debt-to-equity of 0.14 and asset turnover of 1.34x. Revenue per employee stood at EUR 92.5K, while profit per employee was EUR 9.7K, reflecting moderate operational productivity in the latest financial year.